U.S. Tobacco Stock News

NYSE:ARDT
NYSE:ARDTHealthcare

Ardent Health (ARDT) Could Be 8% Undervalued As Lower Earnings Reset Guidance

Ardent Health (ARDT) is in focus after second quarter 2026 results showed much lower net income and earnings per share than a year earlier, along with reduced full year earnings guidance for 2026. See our latest analysis for Ardent Health. Despite the earnings reset and lowered guidance, Ardent Health's recent share price return has been firm. The stock has recorded a 7 day gain of 8.25% and a year to date share price return of 33.68%. However, the 1 year total shareholder return is slightly...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network

On 6 August 2026, CellCarta Inc. said it would add Tempus AI to its CDx Commercialization Lab Network, with Tempus using its Tempus Hub to manage provider test ordering, sample routing to CellCarta, and result delivery for oncology-focused companion diagnostics in the U.S. This collaboration links Tempus AI’s ordering and data platform with CellCarta’s development and regulatory capabilities, aiming to close the gap between CDx approval and real-world clinical access for cancer...
NYSE:CRI
NYSE:CRILuxury

Carter's (CRI) Posts Stronger Earnings And New Guidance, Is It Still Below Fair Value?

Stronger earnings and fresh guidance reshape the Carter's story Carter's (CRI) is back in focus after reporting much higher second quarter and first half 2026 earnings compared with 2025, alongside new guidance that points to continued sales growth for the rest of the year. See our latest analysis for Carter's. The latest results and updated guidance come after a strong run in Carter's share price, with a 90 day share price return of 13.11% and a year to date share price return of 20.36%...
NYSE:VIA
NYSE:VIASoftware

Via (VIA) Stock Can Revenue Growth Justify Ongoing Losses

Via Transportation stock added 3% today, a calm move for a company that just put a high growth, still loss making model back under the spotlight. The real story is not whether the stock popped or faded. It is whether investors believe the revenue engine and margin trajectory in this quarter are strong enough to justify paying up for a business that still reports losses. The headline from Via Transportation’s Q2 is clear. Revenue reached about US$136m and the adjusted earnings before interest,...
NYSE:BX
NYSE:BXCapital Markets

Blackstone (BX) Backs AI Data Centers As TXNM Merger Scrutiny Drags On

Blackstone (NYSE:BX) has invested in AI data center company Firmus alongside investors such as Nvidia and Coatue, expanding its exposure to AI infrastructure. The Firmus funding round positions Blackstone in a growing ecosystem of capital flowing into data center and AI related assets. Separately, Blackstone's extended merger agreement with TXNM Energy remains under regulatory and legal scrutiny, with public calls for customer rate credits adding pressure. The combination of the Firmus...
NasdaqGS:ALGM
NasdaqGS:ALGMSemiconductor

Is Allegro MicroSystems (ALGM) A Bargain As Strong Earnings And Guidance Lift Hopes?

Allegro MicroSystems (ALGM) has drawn fresh attention after reporting first quarter sales of US$259.24 million and net income of US$15.87 million, along with new guidance indicating higher net sales for the second quarter. See our latest analysis for Allegro MicroSystems. At a share price of US$43.77, Allegro MicroSystems has a year to date share price return of 62.65%, while the 1 year total shareholder return of 42.25% points to strong but recently cooling momentum. This follows a 30 day...
NasdaqGS:POWL
NasdaqGS:POWLElectrical

Is Earnings Momentum And Selective M&A Activity Altering The Investment Case For Powell Industries (POWL)?

Powell Industries, Inc. recently reported higher third-quarter and nine‑month fiscal 2026 sales and earnings year on year, while its board reaffirmed a quarterly dividend of US$0.09 per share payable in September 2026. At the same time, management highlighted an active but selective M&A pipeline, focusing on acquisitions that could expand complementary products and services despite what it views as rich sector valuations. Building on this earnings momentum and disciplined acquisition stance,...
NYSE:AIZ
NYSE:AIZInsurance

Assurant (AIZ) Stock May Be A Bargain At Today’s Price

Assurant stock has delivered a strong 112.2% return over the past three years, yet the valuation signals are split, with the Excess Returns intrinsic value estimate suggesting the shares trade below intrinsic value while earnings based multiples point to a richer price. Assurant's 112.2% three-year return highlights how strongly the share price has rewarded long-term holders. Future valuation may be supported if the company can sustain reliable cash generation, although any pressure on...
NYSE:EHC
NYSE:EHCHealthcare

Encompass Health (EHC) Is Up 12.7% After Raising 2026 Guidance And Completing Major Buyback Program – Has The Bull Case Changed?

Encompass Health reported past second-quarter 2026 results with net operating revenue of US$1,597.4 million and net income of US$153.9 million, alongside higher earnings per share versus a year earlier. The company also raised its full-year 2026 revenue guidance and completed a long-running share repurchase program that has retired nearly one-tenth of its shares. We’ll now examine how Encompass Health’s raised 2026 revenue guidance shapes its investment narrative and what it may mean for...
NasdaqCM:PRCH
NasdaqCM:PRCHInsurance

Porch Group (PRCH) Is Up 9.7% After Strong Q2 Profit, 2026 Upgrade and ESOP Shelf Filing

In late July 2026, Porch Group, Inc. reported second-quarter sales of US$140.88 million and net income of US$5.6 million, alongside filing a US$28.428 million shelf registration for 2,300,000 common shares tied to an ESOP-related offering. The combination of stronger quarterly profitability, higher full-year guidance and an ESOP-linked shelf filing highlights how Porch is pairing operational progress with added flexibility in its capital structure and employee incentives. With Porch...
NasdaqGM:PVLA
NasdaqGM:PVLABiotechs

Palvella Therapeutics (PVLA) Earnings And QTORIN Hopes Keep Undervaluation In Focus

Palvella Therapeutics earnings and new shelf filing set the tone Palvella Therapeutics (PVLA) reported second quarter 2026 results on 4 August, with net loss and loss per share both wider than a year earlier. The company also filed a new shelf registration tied to an ESOP related offering. See our latest analysis for Palvella Therapeutics. The earnings release and new ESOP related shelf registration came alongside very strong momentum in Palvella Therapeutics' stock. The latest close at...